Clinical Trials: Renal Cell Carcinoma

Mobile : Southern Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Scottsdale :

AMG 172 First in Human Study in Patients With Kidney Cancer

Scottsdale : Research Site

AMG 172 First in Human Study in Patients With Kidney Cancer

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Jonesboro : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Burbank : Providence Health and Services

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Duarte : City of Hope

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

La Jolla : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Los Angeles : David Geffen School of Medicine at UCLA

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Los Angeles : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

San Francisco : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Santa Clara : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Stanford : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Walnut Creek : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Denver : Rocky Mountain Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

New Haven : Yale University School Of Medicine

Phase I Biomarker Study (BMS-936558)

New Haven : Yale University School of Medicine

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Fort Myers : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Gainesville : University of Florida, Shands Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Tampa : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Tampa : H Lee Moffitt Cancer Center

Phase I Biomarker Study (BMS-936558)

Athens : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Atlanta : Emory University Winship Cancer Center

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Elgin : Sherman Health

SWOG S0931 : Ph III Everolimus/Placebo Completely Resct (Rad or Part nephrect), Clear cell or non-clear ok), No Mets. N0 or pNx if clinical N0. No collect duct /medullary dz. Either ***Intermediate Hi Risk ={pT1b G3-4; pT2a-b G1-4; pT3a G1-2 no adrenal invlvmnt} OR ***Very Hi Risk ={pT3a G3-4 no adrenal invlvmnt; pT3b-c G any; pT4 G any; pT any G any N+ (fully resctd)}. + renal vein margins OK if no renal vein wall invasion at margin.

View More »

Chicago : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Chicago : Northwestern University, Robert H. Lurie Comprehensive Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Chicago : University Of Chicago Medical Center

Phase I Biomarker Study (BMS-936558)

Chicago : The University of Chicago

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Galesburg : Medical & Surgical Specialists, LLC

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Beech Grove : St. Francis Cancer Research Foundation

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Fort Wayne : Fort Wayne Oncology & Hematology, Inc

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Goshen : Center for Cancer Care at Goshen Health System

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Indianapolis : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Indianapolis : Central Indiana Cancer Centers

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

View More »

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Lafayette : Horizon Oncology Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Muncie : IU Health at Ball Memorial Hospital Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

South Bend : Northern Indiana Cancer Research Consortium

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Iowa City : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Sioux City : Siouxland Hematology Oncology Associates, LLP, Nylen Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Kansas City : University of Kansas Medical Center

A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Topeka : Stormont-Vail Cotton O'Neil Cancer Center

A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma

Wichita : Cancer Center of Kansas

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Baton Rouge : Medical Oncology, LLC

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Baltimore : Sidney Kimmel Comprehensive Cancer Center at John Hopkins Hospital

A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer

Baltimore : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Baltimore : Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)

Baltimore : Sidney Kimmel Comprehensive Cancer Center at John Hopkins Hospital

Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

Baltimore : The Bunting-Blaustein Cancer Research Building

Phase I Biomarker Study (BMS-936558)

View More »

Baltimore : University of Maryland Greenebaum Cancer Center

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Boston : Dana Farber Cancer Institute

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer

Boston : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Boston : Beth Israel Deaconess Medical Center

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

View More »

Boston : Beth Israel Deaconess Medical Center

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Boston : Beth Israel Deaconess Medical Center`

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Dana-Farber Cancer Institute

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Massachusetts General Hospital

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Boston : Dana Farber Cancer Inst

Phase I Biomarker Study (BMS-936558)

Boston : Massachusetts General Hospital Cancer Center

Safety Study of MGA271 in Refractory Cancer

Burlington : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Ann Arbor : St. Joseph Mercy Hospital

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Ann Arbor : University Of Michigan Medical Center

Phase I Biomarker Study (BMS-936558)

Ann Arbor : The University of Michigan Health System

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Detroit : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Detroit : Henry Ford Hospital

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Grand Rapids : Cancer & Hematology Centers of Western Michigan

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Wyoming : Metro Health Cancer Care

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Rochester : Mayo Clinic

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

St. Louis Park : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Tupelo : North Mississippi Hematology & Oncology Associates, Ltd.

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Saint Louis : Research Site

AMG 172 First in Human Study in Patients With Kidney Cancer

St. Louis : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Lincoln : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Omaha : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Omaha : Methodist Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Las Vegas : Comprehensive Cancer Centers of Nevada & US Oncology Research

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Las Vegas : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Lebanon : Mary Hitchcock Memorial Hospital, NH

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Lebanon : Dartmouth-Hitchcock Medical Center

BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)

Hackensack : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Albuquerque : Presbyterian Medical Group

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Albuquerque : University of New Mexico Cancer Care Alliance

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Manhasset : Biomedical Research Alliance of New York, LLC

Study for high risk recurrence of renal cell carcinoma after surgical treatment

View More »

Albany : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Buffalo : Roswell Park Cancer Institute

A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer

Buffalo : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Buffalo : Roswell Park Cancer Institute

Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

New York : Memorial Sloan Kettering Cancer Center

A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer

New York : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

New York : Tisch Cancer Institute at Mount Sinai Medical Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

New York : Memorial Sloan Kettering Cancer Center

Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)

Chapel Hill : University of North Carolina, Lineberger Comprehensive Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Chapel Hill : North Carolina Cancer Hospital (UNC)

Neoadjuvant Pazopanib in Renal Cell Carcinoma

Charlotte : Blumenthal Cancer Center

BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)

Durham : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Durham : Duke University Medical Center

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Cleveland : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Columbus : Ohio State University

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Columbus : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Portland : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Portland : Providence Portland Med Ctr

Phase I Biomarker Study (BMS-936558)

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Philadelphia : Fox Chase Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Philadelphia : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Philadelphia : Fox Chase Cancer Center

BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)

Philadelphia : Fox Chase Cancer Center

Phase I Biomarker Study (BMS-936558)

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

Safety Study of MGA271 in Refractory Cancer

Providence : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Charleston : Medical University of South Carolina (MUSC)

Neoadjuvant Pazopanib in Renal Cell Carcinoma

Chattanooga : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Germantown : The Jones Clinic

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Memphis : The West Clinic

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Memphis : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Nashville : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Nashville : Vanderbilt Univeristy Medical Center

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

Nashville : Tennessee Oncology, Pllc

BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)

Nashville : Vanderbilt-Ingram Cancer Ctr

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Nashville : Sarah Cannon Research Institute

Safety Study of MGA271 in Refractory Cancer

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Austin : Texas Oncology-Austin North

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Bedford : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Corpus Christi : Coastal Bend Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Dallas : Texas Oncology-Baylor, Charles A. Sammons Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Dallas : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Dallas : Texas Oncology, PA

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Houston : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Houston : Methodist Hospital Research Institute

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Houston : UT MD Anderson Cancer Center Updated

Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)

San Antonio : CTRC at The UT Health Science Center at San Antonio

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Norfolk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Various Cities : Research Center Updated

Kidney Cancer (Clear Cell Carcinoma) Study - L2201

View More »

Seattle : Seattle Cancer Care Alliance

A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer

Seattle : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Seattle : University of Washington, Seattle Cancer Care Alliance

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Madison : University Of Wisconsin Carbone Cancer Center

Phase I Biomarker Study (BMS-936558)

Milwaukee : University of Wisconsin, Clinical Cancer Center

BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma

Algiers : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Capital Federal : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Córdoba : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Rosario : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

San Miguel de Tucumán : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Santa Fe : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Salzburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Vienna : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hasselt : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Liège : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Wilrijk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Barretos : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Belo Horizonte : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Curitiba : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ijui : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

São Paulo : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Calgary : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Calgary : Local Institution

BMS-936558 (MDX-1106) In Combination With Sunitinib or Pazopanib in Subjects With Metastatic Renal Cell Carcinoma (RCC)

Edmonton : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Halifax : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hamilton : Juravinski Cancer Center

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

View More »

Hamilton : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

London : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Moncton : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Montreal : Montreal General Hospital

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Montreal : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Oshawa : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ottawa : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Quebec : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Toronto : Princess Margaret Hospital

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Toronto : Sunnybrook Odette Cancer Center, Toronto

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Toronto : University Health Network, Princess Margaret Hospital

A Study of Neoadjuvant Sutent for Patients With Renal Cell Carcinoma

Toronto : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Toronto : Toronto General Hospital

Efficacy of Ultrasound Contrast Agent to Assess Renal Masses

Vancouver : BC Cancer Agency Vancouver Centre

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

Vancouver : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Santiago : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Viña del Mar : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Beijing : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hangzhou : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Shanghai : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Tianjin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Brno : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hradec Kralove : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Novy Jicin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Olomouc : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ostrava - Poruba : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Plzen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Praha 2 : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Praha 8 : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Aarhus : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

DK-2730 Herlev : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Odense C : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Cairo : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Helsinki : Local Institution

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Angers cedex 9 : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Bordeaux : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Caen Cedex 05 : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hyeres : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Le Mans : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Marseille cedex 5 : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Paris : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Paris Cedex 15 : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Reims : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Rennes : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Saint Herblain : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Strasbourg Cedex : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Toulouse : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Aachen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Berlin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Berlin : Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30

Exercise for Patients With Renal Cell Cancer Receiving Sunitinib

Bonn : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Braunschweig : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Chemnitz : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Dessau : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Duisburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Eisleben : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Erlangen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Essen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Freiburg : iOMEDICO

Tumor Registry of Advanced Renal Cell Carcinoma

Goslar : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Halle : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hamburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Hannover : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Homburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Kirchheim : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Mainz : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Marburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Moenchengladbach : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Muenchen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Muenster : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Neuss : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Sigmaringen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Stuttgart : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Tuebingen : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ulm : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Velbert : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Weiden : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Athens : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Patra : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Thessaloniki : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Budapest : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Nyíregyháza : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Szombathely : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Chandigard : Pfizer Investigational Site Updated

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Co.Cork : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Cork : Cork University Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

Dublin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Dublin : Mater Misericordiae University Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

Dublin : Mater Private Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

View More »

Dublin : Beaumont Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

Galway : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Galway : Galway University Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

Limerick : MidWestern Regional Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

Tallaght, Dublin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Waterford : Waterford Regional Hospital

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study

Haifa : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Jerusalem : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Petach-Tikva : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Rehovot : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Tel Aviv : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Zrifin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Arezzo : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Bologna : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Candiolo (TO) : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Milano : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Modena : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Napoli : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Pavia : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Roma : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Siena : Local Institution

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Terni : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Fukuoka : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Fukuoka-shi : Kyusyu University Hospital

Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Hokkaido : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Osaka : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Osakasayama : Kinki University Hospital

Temsirolimus (Torisel) Special Investigation (Regulatory Post Marketing Commitment Plan)

View More »

Shizuoka : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Tokyo : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Yamagata : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Daejeon : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Goyang-si, Gyeonggi-do : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Jeonju : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Seongnam-si, : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Seoul : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

songpa-gu, Seoul : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Amsterdam : VU Universtiy Medical Center

Dalteparin in Combination With Sunitinib in Patients With Metastatic Kidney Cancer

Gdansk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Konin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Krakow : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Lublin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Warszawa : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Wroclaw : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Arkhangelsk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Barnaul : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Chelyabinsk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ekaterinburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Kazan : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Moscow : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Obninsk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Omsk : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Rostov-na-Donu : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ryazan : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Saint Petersburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

St. Petersburg : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Stavropol : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Ufa, : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Banska Bystrica : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Bratislava : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Kosice : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Martin : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Zilina : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Cape Town : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Durban : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Johannesburg : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Badalona : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Barcelona : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Córdoba : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Madrid : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Málaga : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Oviedo : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Sevilla : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Valencia : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Bangkok : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Chaingmai : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Songkla : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Ariana : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Sousse : Novartis Investigative Site

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma

Ankara : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Izmir : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Brighton : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Cambridge : Cambridge University Hospitals NHS Foundation Trust

HYPAZ: Hypertension Induced by Pazopanib

Cornwall : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Guildford : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

London : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

View More »

Manchester : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Preston : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Swansea : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Wolverhampton : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

Washington : GSK Investigational Site

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)